1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Pharmaceutical Analysis & Statistics

Global Pharmaceutical Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Datamonitor Healthcare

All regions

1-23 of 23 reports

Market Spotlight: Primary Sclerosing Cholangitis

  • $ 16500
  • April 2018
  • 23 pages

This Market Spotlight report covers the Primary Sclerosing Cholangitis market, comprising disease background, treatment overview, key pipeline drugs, clinical trials, and a 10-year global disease prevalence ...

  • Autoimmune Disease
  • Clinical Trial
  • Pathology
  • Pharmaceutical
  • World

Market Spotlight: Overactive Bladder

  • $ 16500
  • April 2018
  • 40 pages

This Market Spotlight report covers the Overactive Bladder market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence ...

  • Incontinence Product
  • OTC
  • Pharmaceutical
  • World
  • Forecast

Market Spotlight: Neuroendocrine tumors (NET)

  • $ 16500
  • April 2018
  • 42 pages

This Market Spotlight report covers the Neuroendocrine Tumors market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent information, a 10-year disease incidence forecast, ...

  • Pharmaceutical
  • Therapy
  • World
  • Supply

Market Spotlight: Amyloidosis

  • $ 16500
  • April 2018
  • 37 pages

This Market Spotlight report covers the amyloidosis market, comprising key marketed and pipeline drugs, key upcoming events, patent information, a 10-year disease incidence forecast, and licensing and ...

  • Endocrine Disease
  • Pathology
  • Pharmaceutical
  • World
  • Market Description

Market Spotlight: Norovirus, Datamonitor Healthcare

  • $ 16500
  • March 2018
  • 20 pages

This Market Spotlight report covers the Norovirus market, comprising key pipeline drugs, clinical trials, and an epidemiological overview.   Key Takeaways  Worldwide, about one out of every ...

  • Infectious Disease
  • Pathology
  • Pharmaceutical
  • World
  • Market Description

Market Spotlight: Uterine Cancer

  • $ 16500
  • March 2018
  • 28 pages

This Market Spotlight report covers the uterine cancer market, comprising key pipeline drugs, clinical trials, patent information, a 10-year disease incidence forecast, and licensing and acquisition deals. ...

  • Cancer
  • Pathology
  • Pharmaceutical
  • World
  • M&A

Market Spotlight: Polycystic Ovary Syndrome (PCOS)

  • $ 16500
  • March 2018
  • 32 pages

This Market Spotlight report covers the Polycystic Ovary Syndrome market, comprising key pipeline and marketed drugs, clinical trials, patent information, and a 10-year disease prevalence forecast, as ...

  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • Netherlands
  • World

Market Spotlight: Basal Cell Carcinoma

  • $ 16500
  • March 2018
  • 32 pages

This Market Spotlight report covers the basal cell carcinoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent information, and licensing and acquisition deals, ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Forecast

Market Spotlight: Irritable Bowel Syndrome (IBS)

  • $ 16500
  • March 2018
  • 41 pages

This Market Spotlight report covers the irritable bowel syndrome (IBS) market, comprising key pipeline and marketed drugs, clinical trials, upcoming regulatory events, patent information, a 10-year disease ...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World

Market Spotlight: Duchenne Muscular Dystrophy (DMD)

  • $ 16500
  • March 2018
  • 35 pages

This Market Spotlight report covers the Duchenne muscular dystrophy  market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-yea ...

  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • World

Market Spotlight: Sickle Cell Anemia

  • $ 16500
  • March 2018
  • 30 pages

This Market Spotlight report covers the sickle cell anemia market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence ...

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • World
  • M&A

Market Spotlight: Hidradenitis Suppurativa

  • $ 16500
  • March 2018
  • 24 pages

This Market Spotlight report covers the Hidradenitis Suppurativa market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, epidemiology, and ...

  • Autoimmune Disease
  • Medical Biotechnology
  • Pathology
  • Pharmaceutical
  • World

Market Spotlight: Uterine Fibroids

  • $ 16500
  • March 2018
  • 27 pages

This Market Spotlight report covers the Uterine Fibroids market, comprising key pipeline and marketed drugs, clinical trials, upcoming events, patent information, a 10-year disease prevalence forecast, ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Big Pharma Diversification Strategies

  • $ 7500
  • March 2018
  • 123 pages

About this report Pressures ranging from continually declining revenues as a result of generics and impending biosimilars launches, to slow RandD productivity and market access restrictions could cause ...

  • Pharmaceutical
  • United States
  • World
  • Market Size

Market Spotlight: Endometriosis

  • $ 16500
  • September 2017
  • 34 pages

This Market Spotlight report covers the Endometriosis market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence ...

  • Genitourinary System Disease
  • Pharmaceutical
  • Therapy
  • World
  • Forecast

Market Spotlight: Migraine

  • $ 16500
  • September 2017
  • 51 pages

This Market Spotlight report covers the Migraine market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, ...

  • OTC
  • Pain Relief
  • Pharmaceutical
  • World
  • Forecast

Wearables are Transforming R&D and Care Delivery

  • $ 5000
  • June 2016
  • 55 pages

Wearables encompass the growing range of gadgets that can be attached to the body to measure certain physiological parameters. They are rapidly being adopted in healthcare, as part of a broader health ...

  • Hospital
  • Pharmaceutical
  • Wearables
  • World
  • Qualcomm Incorporated

Pharma's Patient Centricity

  • $ 5000
  • February 2016
  • 45 pages

Many in the industry agree that patient centricity is a business imperative, but it is unclear precisely what it means in business or organizational terms, and less clear still how to achieve it within ...

  • Pharmaceutical
  • World
  • AstraZeneca PLC

Dengue vaccines

  • $ 5000
  • October 2015
  • 156 pages

Dengvaxia’s ability to reduce the clinical and economic burden of dengue infection will ensure the rollout of vaccination programs in endemic markets, with sales expected to grow until the 2019 launches ...

  • Pharmaceutical
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited

EGA Biosimilars Conference 2015

  • $ 5000
  • May 2015
  • 14 pages

With the entry of the first monoclonal antibody biosimilar in most European markets and approval of the first biosimilar in the US, 2015 promises to be a landmark year for the biosimilars market. The savings ...

  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • World
  • Demand

Beyond-the-Pill Services and Solutions: Pharma’s Next Frontier?

  • $ 5000
  • February 2015
  • 46 pages

Payers and governments are striving toward cost-effective treatment outcomes and more efficient care, and waves of new digital health technologies are offering patients unprecedented opportunities to be ...

  • Pharmaceutical
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Novo Nordisk Group

Managed Entry Agreements

  • $ 7500
  • July 2014
  • 37 pages

Managed entry agreements (MEAs) provide a mechanism to determine the value-based drug pricing that payers demand. They are tough to implement, but will become more widespread as health systems seek proof ...

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • World

Orphan Drug Pricing and Reimbursement

  • $ 7500
  • February 2014
  • 43 pages

The orphan drug market has become increasingly attractive to drug developers. Their focus on unmet need, and (usually) limited target population, facilitates reimbursement, and coupled with high prices ...

  • Pharmaceutical
  • Therapy
  • Europe
  • United Kingdom
  • World



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on